Novozymes A/S (OTCMKTS:NVZMY) Short Interest Update

Novozymes A/S (OTCMKTS:NVZMY) saw a large drop in short interest in the month of February. As of February 13th, there was short interest totaling 5,586 shares, a drop of 79.5% from the January 29th total of 27,243 shares. Based on an average daily volume of 109,725 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily volume of 109,725 shares, the days-to-cover ratio is presently 0.1 days.

Novozymes A/S Stock Performance

OTCMKTS:NVZMY traded up $0.48 during mid-day trading on Friday, hitting $59.01. 686,490 shares of the company traded hands, compared to its average volume of 80,689. The company has a quick ratio of 1.00, a current ratio of 1.61 and a debt-to-equity ratio of 0.26. The stock’s fifty day moving average price is $62.80 and its 200-day moving average price is $62.64. The firm has a market cap of $27.63 billion, a price-to-earnings ratio of 42.15, a price-to-earnings-growth ratio of 1.07 and a beta of 1.10. Novozymes A/S has a one year low of $53.95 and a one year high of $75.99.

Novozymes A/S (OTCMKTS:NVZMY) last posted its quarterly earnings data on Wednesday, February 25th. The biotechnology company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.79 by ($0.44). The company had revenue of $1.18 billion during the quarter, compared to the consensus estimate of $1.22 billion. Novozymes A/S had a return on equity of 6.38% and a net margin of 13.96%. Research analysts anticipate that Novozymes A/S will post 1.82 earnings per share for the current fiscal year.

Novozymes A/S Company Profile

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).